Get started
Author

Luca Campedel

Observed names: Campedel, Luca, L Campedel, L. Campedel, Lucas Campedel
Observed institutions: University Health Network, University of Toronto, Université Clermont Auvergne, Sorbonne Université, Assistance Publique – Hôpitaux de Paris, Pitié-Salpêtrière Hospital, Centre Hospitalier Universitaire de Clermont-Ferrand, Hôpital Saint-Louis, Unité de recherche sur les maladies cardiovasculaires et métaboliques, Centre Hospitalier Universitaire de Saint-Étienne, Hôpital Tenon, Onco-Urologie Prédictive, Université Pierre-et-Marie-Curie
ORCID: 0000-0002-0046-0969
Observed ORCID: 0000-0002-0046-0969
OpenAlex ID: A5031903089
Acute kidney injury in patients treated with immune checkpoint inhibitors
2021 · Shruti Gupta, Samuel A P Short, et al. · Journal for ImmunoTherapy of Cancer · 237
PDF
Escherichia coli –Specific CXCL13-Producing TFH Are Associated with Clinical Efficacy of Neoadjuvant PD-1 Blockade against Muscle-Invasive Bladder Cancer
2022 · Anne-Gaëlle Goubet, Leonardo Lordello, et al. · Cancer Discovery · 84
Immune Checkpoint Therapy Combinations in Adult Advanced MiT Family Translocation Renal Cell Carcinomas
2023 · Omar Alhalabi, Jonathan Thouvenin, et al. · The Oncologist · 37
PDF
Shorter versus longer corticosteroid duration and recurrent immune checkpoint inhibitor-associated AKI
2022 · Shruti Gupta, Clara Garcia-Carro, et al. · Journal for ImmunoTherapy of Cancer · 37
PDF
Efficacy of Cabozantinib in Metastatic MiT Family Translocation Renal Cell Carcinomas
2022 · Jonathan Thouvenin, Omar Alhalabi, et al. · The Oncologist · 37
PDF
REchallenge of NIVOlumab (RENIVO) or Nivolumab-Ipilimumab in Metastatic Renal Cell Carcinoma: An Ambispective Multicenter Study
2022 · Charles Vauchier, Edouard Auclin, et al. · Journal of Oncology · 32
PDF
Prognostic value of anthropometric measures extracted from whole-body CT using deep learning in patients with non-small-cell lung cancer
2020 · Paul Blanc-Durand, Luca Campedel, et al. · European Radiology · 32
Development and clinical validation of a simple and fast UPLC-ESI-MS/MS method for simultaneous quantification of nine kinase inhibitors and two antiandrogen drugs in human plasma: Interest for their therapeutic drug monitoring
2021 · Benoit Llopis, Pascal Robidou, et al. · Journal of Pharmaceutical and Biomedical Analysis · 22
Metastatic Renal Medullary and Collecting Duct Carcinoma in the Era of Antiangiogenic and Immune Checkpoint Inhibitors: A Multicentric Retrospective Study
2022 · Zoé Guillaume, Emeline Colomba, et al. · Cancers · 14
PDF
Acute kidney injury in patients receiving pembrolizumab combination therapy versus pembrolizumab monotherapy for advanced lung cancer
2022 · Shruti Gupta, Ian A. Strohbehn, et al. · Kidney International · 12
PDF
Efficacy of cabozantinib in advanced MiT family translocation renal cell carcinomas (TRCC).
2021 · Jonathan Thouvenin, Omar Alhalabi, et al. · Journal of Clinical Oncology · 11
Negative Relationship between Post-Treatment Stromal Tumor-Infiltrating Lymphocyte (TIL) and Survival in Triple-Negative Breast Cancer Patients Treated with Dose-Dense Dose-Intense NeoAdjuvant Chemotherapy
2022 · Sylvie Giacchetti, Lilith Faucheux, et al. · Cancers · 9
PDF
2364MO Durvalumab (D) +/- tremelimumab (T) in combination with dose-dense MVAC (ddMVAC) as neoadjuvant treatment in patients with muscle-invasive bladder carcinoma (MIBC): Results of NEMIO, a randomized phase I-II trial
2023 · C. Thibault, M. Bennamoun, et al. · Annals of Oncology · 8
PDF
Prognostic value of programmed death ligand‐1 and programmed death‐1 expression in patients with upper tract urothelial carcinoma
2023 · Luca Campedel, Eva Compérat, et al. · British Journal of Urology · 7
Inclusion of patients with chronic kidney disease in randomized phase 3 clinical trials in patients with prostate, breast, lung, and colorectal cancer
2022 · Matthieu Delaye, Adrien Rousseau, et al. · Cancer Medicine · 7
Malignant Histiocytosis With PD-L1 Expression—Dramatic Response to Nivolumab
2022 · Luca Campedel, Jean-François Emile, et al. · Mayo Clinic Proceedings · 6
PDF
Prognostic Impact of Stromal Immune Infiltration before and after Neoadjuvant Chemotherapy (NAC) in Triple Negative Inflammatory Breast Cancers (TNIBC) Treated with Dose-Dense Dose-Intense NAC
2020 · Luca Campedel, Paul Blanc-Durand, et al. · Cancers · 6
PDF
Radiotherapy for oligoprogressive disease in non-small cell lung cancer treated with pembrolizumab in first-line setting: a retrospective study
2024 · Camille Santonja, Paul Gougis, et al. · Translational Lung Cancer Research · 5
Cancer de prostate métastatique résistant à la castration et inhibiteurs de PARP : de la génomique tumorale aux nouvelles associations thérapeutiques
2024 · Stéphane Oudard, Marc-Olivier Timsit, et al. · Bulletin du Cancer · 5
Cytochrome P-450-mediated herb and food–drug interactions can be identified in cancer patients through patient self-reporting with a tablet application: results of a prospective observational study
2022 · P. Gougis, A. Géraud, et al. · ESMO Open · 5
PDF
Development and organization of onco-nephrology in France, comment on “The path toward the creation of the American Society of Onco-Nephrology (ASON)”
2022 · Matthieu Delaye, Mélanie Try, et al. · Journal of Onco-Nephrology · 4
Comparaison des caractéristiques et des pronostics des patients avec et sans cancer actif hospitalisés pour une infection à SARS-CoV-2
2021 · Charlotte Fenioux, Yves Allenbach, et al. · Bulletin du Cancer · 4
PDF
Le cancer de la prostate neuro-endocrine : histoire naturelle, caractéristiques moléculaires, prise en charge et perspectives
2017 · Luca Campedel, Myriam Kossaï, et al. · Bulletin du Cancer · 4
Intra-individual Dose Escalation of Abiraterone According to Its Plasma Exposure in Patients with Progressive Metastatic Castration-Resistant Prostate Cancer: Results of the OPTIMABI Trial
2024 · Jérôme Alexandre, Stephane Oudard, et al. · Clinical Pharmacokinetics · 3
Correction: Acute kidney injury in patients treated with immune checkpoint inhibitors
2023 · Gupta, Shruti, Short, Samuel A.P., et al. · Journal for ImmunoTherapy of Cancer · 3
PDF
Works count: 80
Citation count: 677
H-index: 11
I10-index: 12
Year
Topic
Type